Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE2
This is a single-arm, multi-center phase II study to evaluate the efficacy ...
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE3
The study is to evaluate the efficacy of KL-A167 combined with cisplatin an...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences